Hansard Adam
- SEC CIK
- 0001805556
No open-market purchases or sales filed in the past year.
Current role at each company
- APLT Applied Therapeutics, Inc.Chief Commercial Officeras of Mar 18, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Hansard Adam as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 18, 2024 (view filing) | Mar 14 | 4 days | Hansard AdamChief Commercial Officer | SSale | −48.9K | $5.39 | −$263.4K | −6.3%732.9K after | |
| Dec 1, 2023 (view filing) | Nov 30 | 1 day | Hansard AdamChief Commercial Officer | SSale | −965 | $1.97 | −$1.90K | −0.3%381.8K after | |
| Sep 29, 2023 (view filing) | Sep 27 | 2 days | Hansard AdamChief Commercial Officer | SSale | −9.72K | $2.70 | −$26.2K | −2.5%382.8K after | |
| Jan 13, 2023 (view filing) | Jan 11 | 2 days | Hansard AdamChief Commercial Officer | SSale | −4.50K | $0.91 | −$4.09K | −4.6%92.5K after |